Status:
UNKNOWN
Consequences of Temporomandibular Disorder on Balance Control
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Temporomandibular Disorder
Pathophysiology
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
To evaluate the effects of the temporomandibular disorder (TMD) and its therapeutic care on postural control in somato-sensory and visual sensitization compared to control subjects matched on age, sex...
Detailed Description
Primary objective: to evaluate the effects of the temporomandibular disorder (TMD) and its therapeutic care on postural control in somato-sensory and visual sensitization compared to control subjects ...
Eligibility Criteria
Inclusion
- Patient group: TMD patients, care: occlusal splint therapy, behavioral advices
- Control group: matched with TMD patients (age, sex, lifestyle).
Exclusion
- Patient group: treatment generating secondary effects in postural control (psychotrop, antidepressor, antihypertensive drugs); osteoarticular pathologies and recent trauma (\< 4 months); vertigo and dysequilibrium (\< 6 months), whiplash
- Control group: id. and TMD.
Key Trial Info
Start Date :
June 19 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 25 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03283839
Start Date
June 19 2017
End Date
June 25 2020
Last Update
January 18 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de NANCY
Nancy, France, 54000